Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2093

1.

Trans-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear Imaging.

Stéen EJL, Jørgensen JT, Johann K, Norregaard K, Sohr B, Svatunek D, Birke A, Shalgunov V, Edem PE, Rossin R, Seidl C, Schmid F, Robillard MS, Kristensen JL, Mikula H, Barz M, Kjaer A, Herth MM.

ACS Nano. 2019 Dec 10. doi: 10.1021/acsnano.9b06905. [Epub ahead of print]

PMID:
31820928
2.

Site-agnostic biomarker-guided oncology drug development.

Jørgensen JT.

Expert Rev Mol Diagn. 2019 Dec 12:1-10. doi: 10.1080/14737159.2020.1702521. [Epub ahead of print]

PMID:
31813299
3.

The effects of growth hormone on adipose tissue: old observations, new mechanisms.

Kopchick JJ, Berryman DE, Puri V, Lee KY, Jorgensen JOL.

Nat Rev Endocrinol. 2019 Nov 28. doi: 10.1038/s41574-019-0280-9. [Epub ahead of print] Review.

PMID:
31780780
4.

Prophylactic arterial ligation following transoral robotic surgery: A systematic review and meta-analysis.

Bollig CA, Gilley DR, Ahmad J, Jorgensen JB.

Head Neck. 2019 Nov 28. doi: 10.1002/hed.26020. [Epub ahead of print] Review.

PMID:
31778006
5.

Redundancy in regulation of lipid accumulation in skeletal muscle during prolonged fasting in obese men.

Høgild ML, Gudiksen A, Pilegaard H, Stødkilde-Jørgensen H, Pedersen SB, Møller N, Jørgensen JOL, Jessen N.

Physiol Rep. 2019 Nov;7(21):e14285. doi: 10.14814/phy2.14285.

6.

Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL).

Jain N, Keating MJ, Thompson PA, Ferrajoli A, Burger JA, Borthakur GM, Takahashi K, Estrov ZE, Fowler NH, Kadia TM, Konopleva MY, Alvarado Y, Yilmaz M, DiNardo CD, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen JL, Wang SA, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian HM, Gandhi V, Wierda WG.

Blood. 2019 Nov 13;134(Supplement_1):34. doi: 10.1182/blood-2019-131847.

PMID:
31724006
7.

Injection molded open microfluidic well plate inserts for user-friendly coculture and microscopy.

Day JH, Nicholson TM, Su X, van Neel TL, Clinton I, Kothandapani A, Lee J, Greenberg MH, Amory JK, Walsh TJ, Muller CH, Franco OE, Jefcoate CR, Crawford SE, Jorgensen JS, Theberge AB.

Lab Chip. 2019 Nov 12. doi: 10.1039/c9lc00706g. [Epub ahead of print]

PMID:
31712791
8.

The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival.

Yilmaz M, Kantarjian H, Wang X, Khoury JD, Ravandi F, Jorgensen J, Short NJ, Loghavi S, Cortes J, Garcia-Manero G, Kadia T, Sasaki K, Konopleva M, Takahashi K, Wierda W, Jain N, Verstovsek S, Estrov Z, Bose P, Pierce S, Garris R, O'Brien S, Jabbour E.

Am J Hematol. 2019 Nov 3. doi: 10.1002/ajh.25671. [Epub ahead of print]

PMID:
31682008
9.

Microbial Danger Signals Control Transcriptional Induction of Distinct MHC Class I L Lineage Genes in Atlantic Salmon.

Svenning S, Gondek-Wyrozemska AT, van der Wal YA, Robertsen B, Jensen I, Jørgensen JB, Edholm ES.

Front Immunol. 2019 Oct 11;10:2425. doi: 10.3389/fimmu.2019.02425. eCollection 2019.

10.

Development and Implementation of a Culturally Appropriate Education Program to Increase Cervical Cancer Screening among Maasai Women in Rural Tanzania.

Lidofsky A, Miller A, Jorgensen J, Tajik A, Tendeu K, Pius D, Mallange E, Dougherty A.

Ann Glob Health. 2019 Oct 17;85(1):127. doi: 10.5334/aogh.2503.

11.

Temporal patterns of lipolytic regulators in adipose tissue after acute growth hormone exposure in human subjects: A randomized controlled crossover trial.

Hjelholt AJ, Lee KY, Arlien-Søborg MC, Pedersen SB, Kopchick JJ, Puri V, Jessen N, Jørgensen JOL.

Mol Metab. 2019 Nov;29:65-75. doi: 10.1016/j.molmet.2019.08.013. Epub 2019 Aug 20.

12.

Prevalence of lifestyle characteristics in glucocorticoid users and non-users: a Danish population-based cross-sectional study.

Laugesen K, Petersen I, Pedersen L, Breinholt Larsen F, Jørgensen JOL, Sørensen HTT.

BMJ Open. 2019 Oct 28;9(10):e030780. doi: 10.1136/bmjopen-2019-030780.

13.

Pelvic insufficiency fractures, dose volume parameters and plan optimization after radiotherapy for rectal cancer.

Kronborg CJS, Jørgensen JB, Petersen JBB, Nyvang Jensen L, Iversen LH, Pedersen BG, Spindler KG.

Clin Transl Radiat Oncol. 2019 Sep 10;19:72-76. doi: 10.1016/j.ctro.2019.09.001. eCollection 2019 Nov.

14.

Re: Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis.

Lamont RF, Bagge JR, Vinter CA, Jørgensen JS.

BJOG. 2019 Oct 20. doi: 10.1111/1471-0528.15953. [Epub ahead of print] No abstract available.

PMID:
31631462
15.

Ghrelin does not directly stimulate secretion of glucagon-like peptide-1.

Jepsen SL, Vestergaard ET, Larraufie P, Gribble FM, Reimann F, Jørgensen JOL, Holst JJ, Kuhre RE.

J Clin Endocrinol Metab. 2019 Oct 14. pii: dgz046. doi: 10.1210/clinem/dgz046. [Epub ahead of print]

PMID:
31608930
16.

Epilepsy patients with and without perceived benefit from vagus nerve stimulation: A long-term observational single center study.

Brodtkorb E, Samsonsen C, Jørgensen JV, Helde G.

Seizure. 2019 Nov;72:28-32. doi: 10.1016/j.seizure.2019.09.004. Epub 2019 Sep 19.

PMID:
31563121
17.

Fibroblast Activation Protein is a GH Target: A Prospective Study of Patients with Acromegaly Before and After Treatment.

Arlien-Søborg MC, Grøndahl C, Bæk A, Dal J, Madsen M, Høgild ML, Pedersen SB, Bjerre M, Jørgensen JOL.

J Clin Endocrinol Metab. 2020 Jan 1;105(1). pii: dgz033. doi: 10.1210/clinem/dgz033.

PMID:
31544947
18.

Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy.

Thompson PA, Srivastava J, Peterson C, Strati P, Jorgensen JL, Hether T, Keating MJ, O'Brien SM, Ferrajoli A, Burger JA, Estrov Z, Jain N, Wierda WG.

Blood. 2019 Nov 28;134(22):1951-1959. doi: 10.1182/blood.2019001077.

PMID:
31537528
19.

Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for other Enterococcal species by the Clinical and Laboratory Standards Institute.

Satlin MJ, Nicolau DP, Humphries RM, Kuti JL, Campeau SA, Lewis JS, Weinstein MP, Jorgensen JH; CLSI Subcommittee on Antimicrobial Susceptibility Testing and Ad Hoc Working Group on Revision of Daptomycin Enterococcal Breakpoints.

Clin Infect Dis. 2019 Aug 26. pii: ciz845. doi: 10.1093/cid/ciz845. [Epub ahead of print]

PMID:
31504338
20.

The association of gut microbiota characteristics in Malawian infants with growth and inflammation.

Kamng'ona AW, Young R, Arnold CD, Kortekangas E, Patson N, Jorgensen JM, Prado EL, Chaima D, Malamba C, Ashorn U, Fan YM, Cheung YB, Ashorn P, Maleta K, Dewey KG.

Sci Rep. 2019 Sep 9;9(1):12893. doi: 10.1038/s41598-019-49274-y.

Supplemental Content

Loading ...
Support Center